Amphastar Pharmaceuticals Inc (AMPH)
EBITDA Margin
26.19%
TTM · Period ending:
AMPH EBITDA Margin
Latest reported26.19%period ending
Latest reported26.19%period ending
AMPH TTM EBITDA Margin (15.04% → 26.19%)
TTM ebitda margin
High-resolution chart · PNG
AMPH ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 26.1934% | |
| 26.565% | |
| 29.2639% | |
| 30.58% | |
| 34.4413% | |
| 35.5938% | |
| 37.9317% | |
| 38.3105% | |
| 41.8541% | |
| 39.7522% | |
| 37.2899% | |
| 37.4058% | |
| 30.4136% | |
| 29.2011% | |
| 29.3132% | |
| 27.0038% | |
| 30.4294% | |
| 29.864% | |
| 25.5332% | |
| 18.8979% | |
| 12.3038% | |
| 8.2925% | |
| 8.6298% | |
| 10.9493% | |
| 9.1849% | |
| 10.057% | |
| 6.8632% | |
| 6.4476% | |
| 6.2749% | |
| 4.3434% | |
| 2.6236% | |
| 1.808% | |
| 0.0452% | |
| 3.0124% | |
| 6.225% | |
| 4.6248% | |
| 7.4665% | |
| 10.0349% | |
| 12.0142% | |
| 18.2223% | |
| 14.5574% | |
| 7.1914% | |
| 3.0849% | |
| -5.6325% | |
| -7.2466% | |
| -3.1538% | |
| -1.3166% | |
| 3.299% | |
| 6.7978% | |
| 12.1691% | |
| 13.5022% | |
| 15.0356% |